{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:50:59Z","timestamp":1775263859959,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.antiviral.2020.104907","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T21:32:55Z","timestamp":1597354375000},"page":"104907","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Development of antibody-based assays for high throughput discovery and mechanistic study of antiviral agents against yellow fever virus"],"prefix":"10.1016","volume":"182","author":[{"given":"Zhao","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4023-8000","authenticated-orcid":false,"given":"Andrea","family":"Jurado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0746-9237","authenticated-orcid":false,"given":"Seon-Hui","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju-Tao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles M.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret R.","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2020.104907_bib1","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/CVI.00209-16","article-title":"Development and characterization of monoclonal antibodies to yellow fever virus and application in antigen detection and IgM capture enzyme-linked immunosorbent assay","volume":"23","author":"Adungo","year":"2016","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.antiviral.2020.104907_bib2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.antiviral.2014.12.010","article-title":"Yellow fever virus: genetic and phenotypic diversity and implications for detection, prevention and therapy","volume":"115","author":"Beasley","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104907_bib3","doi-asserted-by":"crossref","first-page":"13001","DOI":"10.1128\/JVI.76.24.13001-13014.2002","article-title":"Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication","volume":"76","author":"Blight","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104907_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/cells8050487","article-title":"Endoplasmic reticulum detergent-resistant membranes accommodate hepatitis C virus proteins for viral assembly","volume":"8","author":"Boyer","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.antiviral.2020.104907_bib5","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1099\/vir.0.18860-0","article-title":"A stable full-length yellow fever virus cDNA clone and the role of conserved RNA elements in flavivirus replication","volume":"84","author":"Bredenbeek","year":"2003","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2020.104907_bib6","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.3201\/eid2210.160875","article-title":"Yellow fever-more a policy and planning problem than a biological one","volume":"22","author":"Calisher","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104907_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007072","article-title":"Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo","volume":"13","author":"de Freitas","year":"2019","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.antiviral.2020.104907_bib8","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.tim.2018.05.012","article-title":"Yellow fever virus: knowledge gaps impeding the fight against an old foe","volume":"26","author":"Douam","year":"2018","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.antiviral.2020.104907_bib9","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.1038\/s41467-018-07478-2","article-title":"Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses","volume":"9","author":"Douam","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2020.104907_bib10","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1084\/jem.20082292","article-title":"Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses","volume":"205","author":"Gaucher","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2020.104907_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1128\/JVI.01253-16","article-title":"A novel benzodiazepine compound inhibits yellow fever virus infection by specifically targeting NS4B protein","volume":"90","author":"Guo","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104907_bib12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.antiviral.2014.04.010","article-title":"An interferon-beta promoter reporter assay for high throughput identification of compounds against multiple RNA viruses","volume":"107","author":"Guo","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104907_bib13","doi-asserted-by":"crossref","first-page":"5808","DOI":"10.1128\/JVI.07207-11","article-title":"Visualizing coronavirus RNA synthesis in time by using click chemistry","volume":"86","author":"Hagemeijer","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104907_bib14","doi-asserted-by":"crossref","first-page":"11779","DOI":"10.1128\/JVI.01525-12","article-title":"Inclusion bodies are a site of ebolavirus replication","volume":"86","author":"Hoenen","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104907_bib15","doi-asserted-by":"crossref","first-page":"15779","DOI":"10.1073\/pnas.0808480105","article-title":"Exploring RNA transcription and turnover in vivo by using click chemistry","volume":"105","author":"Jao","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104907_bib16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.antiviral.2012.12.002","article-title":"Experimental therapies for yellow fever","volume":"97","author":"Julander","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104907_bib17","article-title":"What does the future hold for yellow fever virus? (II)","volume":"9","author":"Klitting","year":"2018","journal-title":"Genes"},{"key":"10.1016\/j.antiviral.2020.104907_bib18","article-title":"What does the future hold for yellow fever virus? (I)","volume":"9","author":"Klitting","year":"2018","journal-title":"Genes"},{"key":"10.1016\/j.antiviral.2020.104907_bib19","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1128\/JVI.03083-12","article-title":"Nuclear localization of dengue virus nonstructural protein 5 does not strictly correlate with efficient viral RNA replication and inhibition of type I interferon signaling","volume":"87","author":"Kumar","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104907_bib20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/978-981-10-8727-1_9","article-title":"The dengue virus replication complex: from RNA replication to protein-protein interactions to evasion of innate immunity","volume":"1062","author":"Lescar","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.antiviral.2020.104907_bib21","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1126\/science.1153263","article-title":"The flavivirus precursor membrane-envelope protein complex: structure and maturation","volume":"319","author":"Li","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2020.104907_bib22","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.antiviral.2013.09.013","article-title":"Ten years of dengue drug discovery: progress and prospects","volume":"100","author":"Lim","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104907_bib23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.antiviral.2017.10.001","article-title":"A cell-based high throughput screening assay for the discovery of cGAS-STING pathway agonists","volume":"147","author":"Liu","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104907_bib24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.antiviral.2017.12.008","article-title":"Enhancing the antiviral potency of ER alpha-glucosidase inhibitor IHVR-19029 against hemorrhagic fever viruses in vitro and in vivo","volume":"150","author":"Ma","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104907_bib25","doi-asserted-by":"crossref","first-page":"8873","DOI":"10.1074\/jbc.M609919200","article-title":"The non-structural protein 4A of dengue virus is an integral membrane protein inducing membrane alterations in a 2K-regulated manner","volume":"282","author":"Miller","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2020.104907_bib26","doi-asserted-by":"crossref","first-page":"8854","DOI":"10.1074\/jbc.M512697200","article-title":"Subcellular localization and membrane topology of the Dengue virus type 2 Non-structural protein 4B","volume":"281","author":"Miller","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2020.104907_bib27","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jcv.2014.08.030","article-title":"Yellow fever","volume":"64","author":"Monath","year":"2015","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2020.104907_bib28","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1128\/AAC.00074-09","article-title":"Identification of inhibitors of yellow fever virus replication using a replicon-based high-throughput assay","volume":"53","author":"Patkar","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104907_bib29","series-title":"MacSynergy II. Version 1.0. User's Manual","author":"Prichard","year":"1993"},{"key":"10.1016\/j.antiviral.2020.104907_bib30","first-page":"9","article-title":"Analysis of combinations of antiviral drugs and design of effective multidrug therapies","volume":"1","author":"Prichard","year":"1996","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2020.104907_bib31","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ni.1688","article-title":"Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans","volume":"10","author":"Querec","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.antiviral.2020.104907_bib32","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1038\/emi.2015.61","article-title":"Sphingosine kinase 2 is a chikungunya virus host factor co-localized with the viral replication complex","volume":"4","author":"Reid","year":"2015","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.antiviral.2020.104907_bib33","doi-asserted-by":"crossref","first-page":"16229","DOI":"10.1038\/s41598-017-16231-6","article-title":"Development of a quantitative NS1-capture enzyme-linked immunosorbent assay for early detection of yellow fever virus infection","volume":"7","author":"Ricciardi-Jorge","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2020.104907_bib34","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1126\/science.4023707","article-title":"Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution","volume":"229","author":"Rice","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2020.104907_bib35","doi-asserted-by":"crossref","first-page":"8475","DOI":"10.1128\/jvi.71.11.8475-8481.1997","article-title":"Proteolytic activation of tick-borne encephalitis virus by furin","volume":"71","author":"Stadler","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104907_bib36","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jviromet.2015.06.006","article-title":"Development and characterization of polyclonal peptide antibodies for the detection of Yellow fever virus proteins","volume":"222","author":"Stock","year":"2015","journal-title":"J Virol Methods"},{"key":"10.1016\/j.antiviral.2020.104907_bib37","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.chom.2009.03.007","article-title":"Composition and three-dimensional architecture of the dengue virus replication and assembly sites","volume":"5","author":"Welsch","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2020.104907_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001255","article-title":"Identification and characterization of the host protein DNAJC14 as a broadly active flavivirus replication modulator","volume":"7","author":"Yi","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104907_bib39","doi-asserted-by":"crossref","first-page":"11815","DOI":"10.1128\/JVI.01022-12","article-title":"Flavivirus replication complex assembly revealed by DNAJC14 functional mapping","volume":"86","author":"Yi","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104907_bib40","doi-asserted-by":"crossref","first-page":"6061","DOI":"10.1021\/jm300171v","article-title":"Design, synthesis, and biological evaluation of N-alkylated deoxynojirimycin (DNJ) derivatives for the treatment of dengue virus infection","volume":"55","author":"Yu","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2020.104907_bib41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.antiviral.2020.104907_bib42","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1038\/ncomms4877","article-title":"A toggle switch controls the low pH-triggered rearrangement and maturation of the dengue virus envelope proteins","volume":"5","author":"Zheng","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2020.104907_bib43","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/rmv.1835","article-title":"Flaviviral NS4b, chameleon and jack-in-the-box roles in viral replication and pathogenesis, and a molecular target for antiviral intervention","volume":"25","author":"Zmurko","year":"2015","journal-title":"Rev. Med. Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220303211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220303211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:33:02Z","timestamp":1759062782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354220303211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":43,"alternative-id":["S0166354220303211"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104907","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of antibody-based assays for high throughput discovery and mechanistic study of antiviral agents against yellow fever virus","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104907","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104907"}}